NCT01424462
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
Clinical trial condition
Multiple Sclerosis, Relapsing-Remitting
Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.
169 public trials
17 recruiting studies
Multiple Sclerosis, Relapsing-Remitting trial results
NCT00930553
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- North Central Neurology Associates, P.C. Cullman, Alabama, United States
- HOPE Research Institute Phoenix, Arizona, United States
- St. Joseph's Hospital and Medical Center Barrow Neurology Clinics - Barrow Neurological Institute Phoenix, Arizona, United States
- Mayo Clinic Arizona (Scottsdale) Scottsdale, Arizona, United States
NCT02579681
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Research site Bari, Italy
- Research site Cagliari, Italy
- Research site Catania, Italy
- Research site Cefalù, Italy
NCT00548405
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- North Central Neurology Associates, P.C. Cullman, Alabama, United States
- Barrow Neurological Institute, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- Hope Research Institute Phoenix, Arizona, United States
- Mayo Clinic Arizona, Department of Neurology Scottsdale, Arizona, United States
NCT00076934
- Conditions
- Ataxia, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +10 more
- Locations
-
- Brigham and Women's Hospital/Harvard Medical School Boston, Massachusetts, United States
Completed
Natalizumab Re-Initiation of Dosing
NCT00306592
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Phoenix, Arizona, United States
- Research Site Scottsdale, Arizona, United States
- Research Site Little Rock, Arkansas, United States
NCT02019550
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Research site Cullman, Alabama, United States
- Research Site Tuscon, Arizona, United States
- Research Site Newport Beach, California, United States
- Research site Fort Collins, Colorado, United States
NCT00587691
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
- Locations
-
- Bellaire Neurology Bellaire, Texas, United States
- Baylor College of Medicine Houston, Texas, United States
NCT00027300
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- East Bay Region Associates in Neurology Berkeley, California, United States
- UC Davis School of Medicine, Department of Neurology Davis, California, United States
- Yale University School of Medicine, Department of Neurology New Haven, Connecticut, United States
NCT01420055
- Conditions
- Anxiety Disorders, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +9 more
- Locations
-
- Novartis Investigative Site Angers, France
- Novartis Investigative Site Agen, France
- Novartis Investigative Site Amiens, France
- Novartis Investigative Site Auxerre, France